# Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes

> **NCT00529230** · — · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 46 (actual)

## Conditions studied

- Advanced Cancer
- Hypogonadism
- Pain

## Interventions

- **BEHAVIORAL:** Questionnaire
- **OTHER:** Blood draws to assess gonadal function

## Key facts

- **NCT ID:** NCT00529230
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2001-12-11
- **Primary completion:** 2004-02-19
- **Final completion:** 2004-02-19
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** Low accrual rate.
- **Last updated:** 2018-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00529230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00529230, "Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00529230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*